ArticleLiver research (Beijing, China)2021

A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice.

Satyanarayana R Pondugula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.